Aleve and Skin hypertrophy - a phase IV clinical study of FDA data

Summary:

Skin hypertrophy is reported as a side effect among people who take Aleve (naproxen sodium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Renagel, and have Blood phosphorus increased.

The phase IV clinical study analyzes which people have Skin hypertrophy when taking Aleve. It is created by eHealthMe based on reports of 68,206 people who have side effects when taking Aleve from the FDA, and is updated regularly.

What is Aleve?

Aleve has active ingredients of naproxen sodium. It is often used in pain. eHealthMe is studying from 70,279 Aleve users. Check the latest studies of Aleve.

What is Skin hypertrophy?

Skin hypertrophy (skin cells enlarges) is found to be associated with 594 drugs and 544 conditions by eHealthMe. Check the latest studies of Skin hypertrophy.

On Jul, 09, 2026

68,206 people reported to have side effects when taking Aleve.
Among them, 22 people (0.03%) have Skin hypertrophy.

Among these 22 people:

How long have people been on Aleve when they have Skin hypertrophy? *

What is the gender of people who have Skin hypertrophy when taking Aleve? *

female: 59.09 %
male: 40.91 %

What is the age of people who have Skin hypertrophy when taking Aleve? *

What are other drugs people take besides Aleve? *

What are other side effects people have besides Skin hypertrophy? *

Rashes (redness): 9 people, 40.91%
Skin Hyperpigmentation (disorders affect the colour of your skin): 8 people, 36.36%
General Physical Health Deterioration (weak health status): 8 people, 36.36%
Oedema Peripheral (superficial swelling): 8 people, 36.36%
Joint Range Of Motion Decreased (disease of joint movement): 8 people, 36.36%
Joint Contracture (a permanent shortening of a muscle or joint): 8 people, 36.36%
Dry Skin: 8 people, 36.36%
Dyspnea (difficult or laboured breathing): 8 people, 36.36%
Nephrogenic Systemic Fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease): 8 people, 36.36%
Weakness: 8 people, 36.36%

What are the existing conditions these people have? *

Nuclear Magnetic Resonance Imaging Brain: 5 people, 22.73%
Blood Phosphorus Increased: 5 people, 22.73%
Nuclear Magnetic Resonance Imaging Abdominal: 3 people, 13.64%
Toothaches (tooth pain): 2 people, 9.09%
Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 2 people, 9.09%
Neck Pain: 2 people, 9.09%
Prurigo (chronic skin disease causing severe itching): 1 person, 4.55%
Prostate Cancer Metastatic: 1 person, 4.55%
High Blood Pressure: 1 person, 4.55%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Aleve and have Skin hypertrophy?

- Check whether Skin hypertrophy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aleve:

Aleve (70,279 reports)

Browse all side effects of Aleve:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Skin hypertrophy:

Skin hypertrophy (594 drugs)

Browse all the conditions that are associated with Skin hypertrophy:

Skin hypertrophy (544 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on naproxen sodium (the active ingredients of Aleve) and Aleve (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.